Differences in serious clinical outcomes of infection caused by specific pneumococcal serotypes among adults
- 1 May 2014
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 32 (21), 2399-2405
- https://doi.org/10.1016/j.vaccine.2014.02.096
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Pneumococcal Serotype Diversity Among Adults in Various Countries, Influenced by Pediatric Pneumococcal Vaccination UptakeClinical Infectious Diseases, 2013
- A nationwide surveillance of invasive pneumococcal disease in adults in Israel before an expected effect of PCV7Vaccine, 2013
- Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic ResistanceJournal of Korean Medical Science, 2013
- Effectiveness and Serotype Coverage: Key Criteria for Pneumococcal Vaccines for AdultsClinical Infectious Diseases, 2012
- Niche and Neutral Effects of Acquired Immunity Permit Coexistence of Pneumococcal SerotypesScience, 2012
- Invasive pneumococcal disease: Association between serotype, clinical presentation and lethalityVaccine, 2011
- Pneumococcal polysaccharide vaccination for adults: new perspectives for EuropeExpert Review of Vaccines, 2011
- Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumoniaEuropean Respiratory Journal, 2010
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate VaccineThe Journal of Infectious Diseases, 2010
- Epidemiology of invasive Streptococcus pneumoniae infections in adults in FinlandEpidemiology and Infection, 1997